Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide

Transplantation

Volumn 72, Issue 9, 2001, Pages 1578-1582

  Waldman, W James ^a   Bickerstaff, Alice ^a   Gordillo, Gayle ^a   Orosz, Kathleen ^a   Knight, Deborah A ^a   Orosz, Charles G ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FIBRIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; PYRIMIDINE; TACROLIMUS;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; IMMUNOSUPPRESSIVE TREATMENT; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0035890446     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200111150-00018     Document Type: Article

References (19)

1. Leflunomide in experimental transplantation: Control of rejection and alloantibody production, reversal of acute rejection and interaction with cyclosporine
2. Pharmacologically induced regression of chronic transplant rejection
3. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection
4. In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: Mechanisms of action
5. Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors
6. Two activities of the immunosuppressive metabolite of leflunomide, A77 1726: Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation
7. Inability of cytomegalovirus infection of cultured endothelial cells to induce HLA class II antigen expression
8. Alloantigenicity of human endothelial cells. IV. Derivation, characterization and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions
9. In vivo activity of leflunomide: Pharmacokinetic analyses and mechanism of immunosuppression
10. Novel mechanism of inhibition of CMV by the experimental immunosuppressive agent leflunomide
11. Growth of microvessels in serum-free matrix culture of rat aorta
12. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide
13. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis
14. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood formation
15. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
16. The spectrum of coronary artery pathologic findings in human cardiac allografts
17. Both alloantigen-dependent and -independent factors influence chronic allograft rejection
18. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection
19. Development of vasa vasorum in the arterially implanted autovein bypass graft and its anastomosis in the dog